These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. Clearfield M; Downs JR; Weis S; Whitney EJ; Kruyer W; Shapiro DR; Stein EA; Langendorfer A; Beere PA; Gotto AM J Womens Health Gend Based Med; 2001 Dec; 10(10):971-81. PubMed ID: 11788107 [TBL] [Abstract][Full Text] [Related]
11. Primary prevention of coronary heart disease: implications of the Air Force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS). Brown AS Curr Cardiol Rep; 2000 Sep; 2(5):439-44. PubMed ID: 10980912 [TBL] [Abstract][Full Text] [Related]
12. Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events. Ridker PM; Shih J; Cook TJ; Clearfield M; Downs JR; Pradhan AD; Weis SE; Gotto AM; Circulation; 2002 Apr; 105(15):1776-9. PubMed ID: 11956118 [TBL] [Abstract][Full Text] [Related]
13. Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Gotto AM Am J Med; 1999 Aug; 107(2A):36S-39S. PubMed ID: 10484239 [TBL] [Abstract][Full Text] [Related]
14. Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group. Gotto AM; Boccuzzi SJ; Cook JR; Alexander CM; Roehm JB; Meyer GS; Clearfield M; Weis S; Whitney E Am J Cardiol; 2000 Dec; 86(11):1176-81. PubMed ID: 11090787 [TBL] [Abstract][Full Text] [Related]
15. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): baseline characteristics and comparison with USA population. Clearfield M; Whitney EJ; Weis S; Downs JR; Shapiro DR; Stein EA; Watson DJ; Langendörfer A; Beere PA; Stamler J; Gotto AM J Cardiovasc Risk; 2000 Apr; 7(2):125-33. PubMed ID: 10879416 [TBL] [Abstract][Full Text] [Related]
16. Establishing the benefit of statins in low-to-moderate--risk primary prevention: the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Gotto AM Atheroscler Suppl; 2007 Aug; 8(2):3-8. PubMed ID: 17588826 [TBL] [Abstract][Full Text] [Related]
17. Insights on treating an over-the-counter-type subgroup: data from the Air Force/Texas Coronary Atherosclerosis Prevention Study Population. Gotto AM Am J Cardiol; 2000 Jun; 85(12A):8E-14E. PubMed ID: 10858488 [TBL] [Abstract][Full Text] [Related]
18. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Gotto AM; Whitney E; Stein EA; Shapiro DR; Clearfield M; Weis S; Jou JY; Langendörfer A; Beere PA; Watson DJ; Downs JR; de Cani JS Circulation; 2000 Feb; 101(5):477-84. PubMed ID: 10662743 [TBL] [Abstract][Full Text] [Related]
19. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin. Downs JR; Clearfield M; Tyroler HA; Whitney EJ; Kruyer W; Langendorfer A; Zagrebelsky V; Weis S; Shapiro DR; Beere PA; Gotto AM Am J Cardiol; 2001 May; 87(9):1074-9. PubMed ID: 11348605 [TBL] [Abstract][Full Text] [Related]
20. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Gotto AM; Whitney E; Stein EA; Shapiro DR; Clearfield M; Weis S; Jou JY; Langendörfer A; Beere PA; Watson DJ; Downs JR; de Cani JS Eur Heart J; 2000 Oct; 21(19):1627-33. PubMed ID: 10988016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]